FierceBiotech 5. Dez. 2025 Praxis claims efficacy success in phase 2 seizure trial, setting up approval talks with FDA
FierceBiotech 5. Dez. 2025 Pfizer Ventures gets behind Chinese biotech's $100M series A to boost R&D hub's capability
FierceBiotech 4. Dez. 2025 GE HealthCare, Mayo Clinic launch digital twin project for personalizing radiation cancer therapy
FierceBiotech 4. Dez. 2025 Paradigm Health raises $78M to revamp clinical research process, inks deal with Roche’s Flatiron
FierceBiotech 4. Dez. 2025 After dodging Biosecure threat, WuXi AppTec faces new security scrutiny from Pentagon: Bloomberg
FierceBiotech 4. Dez. 2025 Crescent waxes pipeline with $80M Kelun deal, bagging ADC to pair with PD-1xVEGF bispecific
FierceBiotech 4. Dez. 2025 Royalty pens $275M financing deal for Denali drug awaiting delayed FDA decision
FierceBiotech 4. Dez. 2025 After more than 20 years, Medtronic claims deep brain stimulation approval for dystonia
FierceBiotech 4. Dez. 2025 A dozen former FDA commissioners blast Prasad's proposed vaccine policy changes
FierceBiotech 4. Dez. 2025 FDA names Tracy Beth Høeg, fresh from vaccine safety probe, as acting head of drug center
FierceBiotech 4. Dez. 2025 FDA floats user fee cuts for early-stage US trials, additional fees for overseas development
FierceBiotech 3. Dez. 2025 Capricor's phase 3 win sets up 2nd approval attempt for Duchenne cell therapy
FierceBiotech 3. Dez. 2025 Olympus-backed robotics startup Swan EndoSurgical taps Stryker vet for CEO